Key statistics
On Friday, MaxCyte Inc (MXCT:LSE) closed at 316.00, -26.51% below its 52-week high of 430.00, set on Jan 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 317.00 |
---|---|
High | 316.00 |
Low | 316.00 |
Bid | 310.00 |
Offer | 340.00 |
Previous close | 317.00 |
Average volume | 7.45k |
---|---|
Shares outstanding | 105.17m |
Free float | 98.51m |
P/E (TTM) | -- |
Market cap | 431.20m USD |
EPS (TTM) | -0.3408 USD |
Data delayed at least 20 minutes, as of Sep 20 2024 16:35 BST.
More ▼
- Holding(s) in Company
- TR-1: Notification of major holdings
- Signing of Strategic Platform License
- MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases
- Exercise of options and PDMR dealing
- Bioprocessing Conference Participation
- MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference
- Total Voting Rights
- Exercise of options and PDMR dealing
- Filing of Form 10-Q
More ▼